Targeting the DFG-out conformation of TTBK1 enables the discovery of selective type II neuroprotective inhibitors

European Journal of Medicinal Chemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles